Research Paper Volume 12, Issue 24 pp 25395—25411

Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC)

Figure 6. The expression of SRD5A3 has prognostic value in various malignant cancers. In the UALCAN website portal, the effect of high and low expression levels of SRD5A3 on the overall survival of (A) skin cutaneous melanoma (SKCM), (B) kidney renal clear cell carcinoma (KIRC), (C) kidney renal papillary cell carcinoma (KIRP), (D) uveal melanoma (UVM), (E) brain lower grade glioma (LGG), (F) breast invasive carcinoma (BRCA), (G) thyroid carcinoma (THCA) and (H) glioblastoma multiforme (GBM) cancer patients.